gemfibrozil has been researched along with Benign Neoplasms in 5 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "All participants of the Helsinki Heart Study (a controlled, 5-year, multi-clinic coronary heart disease (CHD) primary prevention trial with gemfibrozil and placebo) were offered gemfibrozil treatment and twice yearly follow-up for 3." | 5.07 | The Helsinki Heart Study: an 8.5-year safety and mortality follow-up. ( Frick, MH; Hakulinen, T; Heinonen, OP; Huttunen, JK; Koskinen, P; Manninen, V; Mänttäri, M; Teppo, L, 1994) |
| "The relative risks (RRs) of cancer were estimated using Cox regression models." | 2.72 | The sense of coherence and incidence of cancer--role of follow-up time and age at baseline. ( Hakama, M; Poppius, E; Tenkanen, L; Virkkunen, H, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lin, R | 1 |
| Elf, S | 1 |
| Shan, C | 1 |
| Kang, HB | 1 |
| Ji, Q | 1 |
| Zhou, L | 1 |
| Hitosugi, T | 1 |
| Zhang, L | 1 |
| Zhang, S | 1 |
| Seo, JH | 1 |
| Xie, J | 1 |
| Tucker, M | 1 |
| Gu, TL | 1 |
| Sudderth, J | 1 |
| Jiang, L | 1 |
| Mitsche, M | 1 |
| DeBerardinis, RJ | 1 |
| Wu, S | 1 |
| Li, Y | 1 |
| Mao, H | 1 |
| Chen, PR | 1 |
| Wang, D | 1 |
| Chen, GZ | 1 |
| Hurwitz, SJ | 1 |
| Lonial, S | 1 |
| Arellano, ML | 1 |
| Khoury, HJ | 1 |
| Khuri, FR | 1 |
| Lee, BH | 1 |
| Lei, Q | 1 |
| Brat, DJ | 1 |
| Ye, K | 1 |
| Boggon, TJ | 1 |
| He, C | 1 |
| Kang, S | 1 |
| Fan, J | 1 |
| Chen, J | 1 |
| Behiry, S | 1 |
| Rabie, A | 1 |
| Kora, M | 1 |
| Ismail, W | 1 |
| Sabry, D | 1 |
| Zahran, A | 1 |
| Poppius, E | 1 |
| Virkkunen, H | 1 |
| Hakama, M | 1 |
| Tenkanen, L | 1 |
| Huttunen, JK | 1 |
| Heinonen, OP | 1 |
| Manninen, V | 1 |
| Koskinen, P | 1 |
| Hakulinen, T | 1 |
| Teppo, L | 1 |
| Mänttäri, M | 1 |
| Frick, MH | 1 |
| Platts, J | 1 |
1 review available for gemfibrozil and Benign Neoplasms
| Article | Year |
|---|---|
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
Topics: AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Humans; Lipogenesis; Neoplasms; | 2015 |
2 trials available for gemfibrozil and Benign Neoplasms
| Article | Year |
|---|---|
The sense of coherence and incidence of cancer--role of follow-up time and age at baseline.
Topics: Alcohol Drinking; Follow-Up Studies; Gemfibrozil; Humans; Hypolipidemic Agents; Incidence; Male; Mid | 2006 |
The Helsinki Heart Study: an 8.5-year safety and mortality follow-up.
Topics: Adult; Cause of Death; Coronary Disease; Finland; Follow-Up Studies; Gemfibrozil; Humans; Incidence; | 1994 |
2 other studies available for gemfibrozil and Benign Neoplasms
| Article | Year |
|---|---|
Effect of combination sildenafil and gemfibrozil on cisplatin-induced nephrotoxicity; role of heme oxygenase-1.
Topics: Animals; Antineoplastic Agents; Apoptosis; Biomarkers; Cisplatin; Creatinine; Disease Models, Animal | 2018 |
Therapy and clinical trials.
Topics: Cholesterol, HDL; Clinical Trials as Topic; Coronary Disease; Gemfibrozil; Humans; Hyperlipidemias; | 2002 |